Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07096544 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CALM Study: Cardiomems Assisted Lvad Management

Study acronym: CALM
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened
    • Primary completion pushed from Mar 1, 2027 to May 1, 2027
    • Start date changed from estimate of Mar 1, 2026 to May 8, 2026
    • Site details revised
    v5
  2. Primary completion date: Sep 1, 2026 to Mar 1, 2027
    • Start date: Nov 20, 2025 to Mar 1, 2026
    v4
  3. Start date: Sep 1, 2025 to Nov 20, 2025v3
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This prospective, open label, randomized, single-center pilot clinical trial will determine if the rate of heart failure related (HFR) hospitalizations is less in LVAD patients whose PAP is monitored with the CardioMEMS device vs the control patients receiving standard of care treatment.
Trial Details
NCT Number NCT07096544
Lead Sponsor Baylor Research Institute
Conditions
(from sponsor)		 Heart Failure
Related terms Heart Failure
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov